Search

Please use the search box below or the filters provided to fine-tune the results and discover more about our offers, products, customers, and stories.

There are 17903 results
2022: A Remarkable Year for External Control Arms in Clinical Trials

Reading Time: 5 minutes2022 was a remarkable year for external control arms (ECAs) in clinical trials. Developed by Medidata AI, a Synthetic Control Arm (SCA) is an external control arm derived from both cross-industry historical clinical trial data and real world data. In contrast to other external controls—static summary measures that do not adequately account for patient baseline […]

Article

Accelerating Generalizability of Cancer Clinical Trial Results

Reading Time: 4 minutes Substantial research suggests that patients participating in cancer clinical trials of new therapies are a small and largely unrepresentative subset of the United States (US) population with cancer. Compared to the underlying US population with cancer, patients who enroll in cancer clinical trials are younger, otherwise healthier, wealthier, more often White, and less likely to […]

Article

Risk-based Quality Management Growing Rapidly in Clinical Trials: ACRO RBQM Working Group

Reading Time: 2 minutesClinical trials are constantly evolving in response to technological advances, new data analysis methods, and diverse trial designs, such as decentralized clinical trials (DCTs). One of the significant developments in clinical trial management in recent years is implementing a risk-based quality management (RBQM) framework. The adoption of these approaches is increasing due to their efficiency, […]

Article

4 Ways Linking CAR-T Therapy Patients to Real-world Data Is Future-proofing Clinical Development

Reading Time: 4 minutesChimeric antigen receptor T-cell (CAR-T) therapies have demonstrated significant promise in treating hematological and other malignancies.[1] But there are several areas that require a deeper understanding for the development, approval, and sale of CAR-T therapies; these include the long-term therapeutic benefits, risk of serious adverse events, and healthcare resource utilization (HCRU). Due to the risks […]

Article

Medidata AI: New Research on Concurrence of CRS and ICANS in CAR T-cell Treatments

Reading Time: < 1 minuteChimeric antigen receptor (CAR) T-cell treatment is a promising immunotherapy for multiple hematological cancers, especially for patients who have exhausted other treatment options. While CAR-T therapy represents hope for these patients, it can come with serious and life-threatening side effects. Cytokine Release Syndrome (CRS)—sometimes called a cytokine storm—is one of the most common CAR-T cell […]

Article

Managing Clinical Trial Data in a Fast-paced, Complex Environment

Reading Time: 4 minutesThe world of clinical data management is rapidly changing, and so too are the skills and processes associated with today’s data managers. New data sources bring in higher volumes of data at faster speeds, giving teams more insights around patients than ever before. But data managers continue to face challenges with regards to data collection […]

Article

Is Clinical Trial Diversity the New Patient Centricity?

Reading Time: 2 minutes This blog was authored by Alicia Staley. Alicia is the VP of Patient Engagement at Medidata and leads Medidata’s Patient Insights Board. For the past 10 years, no phrase in the clinical trial industry has been overused more than “patient centricity.” Until today. Go to any conference and you’ll see that the new buzzword […]

Article

Quick Take: Medidata &#038; Harvard Business Review Talk Decentralized Clinical Trials

Reading Time: 2 minutes Decentralized clinical trials (DCTs) have revolutionized clinical research. As trials become more complex, precise, and personalized, embracing this new landscape of patient-focused solutions is critical to ensure success and scalability. What has been the impact of DCT platforms, and what should companies consider when evaluating the model for decentralized trials? Medidata Patient Cloud CEO, Anthony […]

Article

Diversity in Clinical Trials: How Pharmaceutical Companies Can Achieve Success Amidst Regulatory Focus

Reading Time: 3 minutesDiversity in clinical trials has been a long-standing issue across clinical research. Studies have historically failed to represent the patient population, with the majority of patients enrolled in trials being White, younger men. This has caused not only gaps in the industry’s understanding of how treatments in certain disease areas broadly affect diverse populations, but […]

Article

Revolutionizing Clinical Studies with Adaptive Trial Designs: Flexibility, Mid-Study Changes, &#038; Expert Teams for Optimal Results

Reading Time: 3 minutesThis blog was authored by Marc Kaufman, Senior Product Director, Product Management at Medidata. Clinical trials are becoming more complex, with an average of 3.6 million data points collected in Phase III studies.1 Despite this and rising development costs, trial approvals and success rates have not improved. Unsurprisingly, adaptive clinical trial designs are being […]

Article

Medidata’s Rave System Provides Proven Flexibility and Scalability for Frictionless Mid-Study Changes

Reading Time: 4 minutesMedidata’s Rave (electronic data capture) system is designed to meet the flexibility challenges of clinical trials. It requires no downtime when executing mid-study changes that are preplanned (adaptive trial design) or unplanned (protocol amendments). Medidata and our customers perform an average of over 30,000 mid-study changes per year (2019-2022) and a total of 300,000+ since 2005, including […]

Article

Is Physical Media Weighing Down Your Clinical Trial End of Study Process?

Reading Time: 3 minutesThis blog was authored by Nicole Montgomery, Director, Product Marketing at Medidata. You’re either riding the innovation wave with a seamless, completely digital, end-of-study process or you’re wasting time and money burning end-of-study PDFs onto physical media. This time-consuming process involves labeling, packaging, relabeling, shipping to the site, and waiting for the site to receive, […]

Article

Looking for more?

Check out the links below

Want to join the Workforce of the Future?

Search, find and apply to job opportunities at Dassault Systèmes

Explore our Network of Partners

Our partners extend our solutions by offering complementary products, expertise, and services

Search the Knowledge Base

Dassault Systèmes customers' one stop to get help and support information